Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Therapeutic Drug Carrier Systems
Fator do impacto: 2.9 FI de cinco anos: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X

Volumes:
Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v27.i6.20
pages 509-545

Microencapsulation: An Acclaimed Novel Drug-Delivery System for NSAIDs in Arthritis

K. M. Manjanna
Department of Pharmaceutics, T.V.M. College of Pharmacy, Bellary Karnataka
B. Shivakumar
Department of Pharmaceutical Chemistry, BLDE College of Pharmacy, Bijapur, Karnataka
T. M. Pramod Kumar
JSS University, JSS College of Pharmacy, Mysore, Karnataka

RESUMO

Arthritis refers to different medical conditions associated with disorders of the primary structures that determine joint functioning, such as bones, cartilage, and synovial membranes. Drug discovery and delivery to retard the degeneration of joint tissues are challenging. Current treatment of different types of arthritis such as osteoarthritis, rheumatoid arthritis, septic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis involves the administration of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, diclofenac, aceclofenac, ibuprofen, flurbiprofen, indomethacin piroxicam, dexibuprofen, ketoprofen, nabumetone, nimesulide, and naproxen, mainly by the oral, parenteral, or topical route. However, the frequent dosing that is required with NSAIDs often leads to patient noncompliance, so drug-delivery technologies should be developed to reduce the frequency of dosing and to allow sustained release of medications. Microencapsulation is one of the novel drug-delivery technologies employed to sustain drug release. This method reduces dosing and eliminates gastrointestinal irritation, thus ultimately improving patient compliance in the pharmacotherapy of arthritis. We provide a comprehensive overview of several microencapsulation technologies used in the treatment of arthritis that may reduce the dose-related adverse effects caused by NSAIDs.


Articles with similar content:

Device-Related Infections: A Review
Journal of Long-Term Effects of Medical Implants, Vol.15, 2005, issue 5
John M. Embil, Donald C. Vinh
Liposome-Based Nanomedicine Therapeutics for Rheumatoid Arthritis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 4
Richard T. Addo, Vikas Kumar, Ruhi Ubale, Firoz Anwar, Mahfoozur Rahman, Sarwar Beg, Sohail Akhter, Raisuddin Ali
Review Article: Fabricated Microparticles: An Innovative Method to Minimize the Side Effects of NSAIDs in Arthritis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 5
Shaivad Shabee Hulhasan Abadi, Afrasim Moin, Gangadharappa Hosahalli Veerabhadrappa
Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 6
Sanaul Mustafa, Roopa S Pai, Gurinder Singh
Osteoarthritis: A Critical Review
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.24, 2012, issue 3-4
Eric Y. Chang, Justin Hata, Richard Panush, Kentaro Onishi, Amol Utturkar, Danielle Perret-Karimi